Neuropeptides
Volume 44, Issue 5 , Pages 363-371 , October 2010

Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice

  • K. Sándor

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • ,
  • V. Kormos

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • Department of Anatomy, Faculty of Medicine, University of Pécs, Pécs, Hungary
    • ,
  • B. Botz

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • ,
  • A. Imreh

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • ,
  • K. Bölcskei

      Affiliations

    • Analgesic Research Laboratory of Gedeon Richter Plc. and the University of Pécs, Pécs, Hungary
    • ,
  • B. Gaszner

      Affiliations

    • Department of Anatomy, Faculty of Medicine, University of Pécs, Pécs, Hungary
    • ,
  • A. Markovics

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • ,
  • J. Szolcsányi

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • ,
  • N. Shintani

      Affiliations

    • Graduate School of Pharmaceutical Sciences, Osaka University, Japan
    • ,
  • H. Hashimoto

      Affiliations

    • Graduate School of Pharmaceutical Sciences, Osaka University, Japan
    • Center for Child Mental Development, Graduate School of Medicine, Osaka University, Japan
    • United Graduate School of Child Development, Osaka University, Kanazawa University and Hamamatsu University School of Medicine, Japan
    • ,
  • A. Baba

      Affiliations

    • Graduate School of Pharmaceutical Sciences, Osaka University, Japan
    • ,
  • D. Reglodi

      Affiliations

    • Department of Anatomy, Faculty of Medicine, University of Pécs, Pécs, Hungary
    • These authors made equal contributions to the present work.
    • ,
  • Zs. Helyes

      Affiliations

    • Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs, Hungary
    • Corresponding Author InformationCorresponding author. Address: Department of Pharmacology and Pharmacotherapy, University of Pécs, Pécs-7624, Szigeti u. 12, Hungary. Tel.: +36 72 536001/5386/5591; fax: +36 72 536218.
    • These authors made equal contributions to the present work.

Received 5 February 2010 ,Accepted 12 June 2010.

References 

  1. Bölcskei K, Helyes Zs, Szabó Á, Sándor K, Pethő G, Elekes K, et al. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain. 2005;117:368–376
  2. Davis-Traber R, Baker S, Lehto SG, Zhong C, Surowy CS, Faltynek CR, et al. Central pituitary adenylate cylase 1 receptors modulate nociceptive behaviours in both inflammation and neuropathic pain states. J. Pain. 2008;9:449–456
  3. Dickinson T, Fleetwood-Walker SM. VIP and PACAP: very important in pain?. Trends Pharmacol Sci. 1999;20:324–329
  4. Dickinson T, Fleetwood-Walker SM, Mitchell R, Lutz EM. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs. Neuropeptides. 1997;31:175–185
  5. Dickinson T, Mitchell R, Robberecht P, Fleetwood-Walker SM. The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy. Neuropharmacology. 1999;38:167–180
  6. Ekblad E. Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon. Regul. Pept. 1999;85:87–92
  7. Fahrenkrug J, Hannibal J. Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract. Neuroscience. 1998;83:1261–1272
  8. Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc. Natl. Acad. Sci. 2001;98:13355–13360
  9. Hashimoto H, Shintani H, Baba A. New insights into the central PACAP-ergic system from the phenotypes of PACAP- and PACAP receptor-knockout mice. Ann. N.Y. Acad. Sci. 2006;1070:75–89
  10. Helyes Zs, Pozsgai G, Börzsei R, Németh J, Bagoly T, Márk L, et al. Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat. Peptides. 2007;28:1847–1855
  11. Jongsma H, Danielsen N, Sundler F, Kanje M. Alteration of PACAP distribution and PACAP receptor binding in the rat sensory nervous system following sciatic nerve transection. Brain Res. 2000;853:186–196
  12. Jongsma H, Pettersson LM, Zhang Y, Reimer MK, Kanje M, Waldenstrom A, et al. Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor. Neuroreport. 2001;12:2215–2219
  13. Laburthe M, Couvineau A, Tan V. Class II G-protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology. Peptides. 2007;28:1631–1639
  14. Mabuchi T, Shintani N, Matsumura S, Okuda-Ashitaka E, Hashimoto H, Muratani T, et al. Pituitary adenylate cyclase-activating polypeptide is required for the development of spinal sensitization and induction of neuropathic pain. J. Neurosci. 2004;24:7283–7291
  15. Macpherson JL, Xiao B, Kwan KY, Dubin AE, Hwang S, Cravatt B, et al. An ion channel essential for sensing chemical damage. J. Neurosci. 2007;27:11412–11415
  16. Malmberg AB, Basbaum AI. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioural and neuroanatomical correlates. Pain. 1998;76:215–222
  17. Meyer RA, Ringkamp M, Campbell JN, Raja SN. Peripheral mechanisms of cutaneous nociception. In:  McMahon SB,  Koltzenburg M editor. Textbook of Pain. Amsterdam: Elsevier; 2006;p. 3–33
  18. Meyer RA, Campbell JN. Myelinated nociceptive afferents account for the hyperalgesia that follows a burn to the hand. Science. 1981;213:1527–1529
  19. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989;164:567–574
  20. Moller K, Zhang YZ, Hakanson R, Luts A, Sjolund B, Uddman R, et al. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience. 1993;57:725–732
  21. Mulder H, Uddman R, Moller K, Zhang YZ, Ekblad E, Alumets J, et al. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience. 1994;63:307–312
  22. Mulder H, Jongsma H, Zhang YZ, Gebre-Medhin S, Sundler F, Danielsen N. Pituitary adenylate cyclase activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation. Mol. Neurobiol. 1999;19:229–253
  23. Muller JM, Debaigt C, Coursaud S, Montoni A, Pineau N, Meunier AC, et al. Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update. Peptides. 2007;28:1655–1666
  24. Narita M, Dun SL, Dun NJ, Tseng LF. Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord. Eur. J. Pharmacol. 1996;311:121–126
  25. Németh J, Reglődi D, Pozsgai G, Szabó Á, Elekes K, Pintér E, et al. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience. 2006;143:223–230
  26. Ohsawa M, Brailoiu GC, Shiraki M, Dun NJ, Paul K, Tseng LF. Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse. Pain. 2002;100:27–34
  27. Onou T, Shimizu T, Sakamoto H, Higashi M, Kanmura Y, Miyata A. Involvement of opioidergic system in supraspinal PACAP analgesia and the tolerance. J. Mol. Neurosci. 2007;33:339–345
  28. Pettersson LM, Heine T, Verge VM, Sundler F, Danielsen N. PACAP mRNA is expressed in rat spinal cord neurons. J. Comp. Neurol. 2004;471:85–96
  29. Riedel W, Neeck G. Nociception, pain, and antinociception: current concepts. Z. Rheumatol. 2001;60:404–415
  30. Said SI. VIP and PACAP in pain and inflammation. Trends. Pharmacol. Sci. 2000;21:57–69
  31. Sakashita Y, Kurihara D, Uchida T, Tatsuno I, Yamamoto T. Involvement of PACAP receptor in primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord. Br. J. Pharmacol. 2001;132:1769–1776
  32. Sándor K, Bölcskei K, McDougall J, Schuelert N, Reglodi D, Elekes K, et al. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Pain. 2009;141:143–150
  33. Sándor K, Helyes Zs, Gyires K, Szolcsányi J, László J. Static magnetic field-induced anti-nociceptive effect and the involvement of capsaicin-sensitive sensory nerves in this mechanism. Life Sci. 2007;81:97–102
  34. Seltzer Z, Dubner R, Shir Y. A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 1990;43:205–218
  35. Shimizu T, Katahira M, Sugawara H, Inoue K, Miyata A. Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord. Regul. Pept. 2004;123:117–122
  36. Somogyvári-Vígh A, Reglődi D. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 2004;10:2861–2889
  37. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 1993;365:170–175
  38. Taiwo YO, Levine JD. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 1991;44:131–135
  39. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain. 1992;51:5–17
  40. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 2009;61:283–357
  41. Weston MC, Peachell PT. Regulation of human mast cell and basophil function by cAMP. Gen. Pharmacol. 1998;31:715–719
  42. Xu XJ, Wiesenfeld-Hallin Z. Intrathecal pituitary adenylate cyclase activating polypeptide facilitates the spinal nociceptive flexor reflex in the rat. Neuroscience. 1996;72:801–804
  43. Yamamoto T, Tatsuno I. Antinociceptive effect of intrathecally administered pituitary adenylate cyclase activating polypeptide (PACAP) on the rat formalin test. Neurosci. Lett. 1995;184:32–35
  44. Zhang Y, Danielsen N, Sundler F, Mulder H. Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation. Neuroreport. 1998;9:2833–2836
  45. Zhang Y, Malmberg AB, Sjolund B, Yaksh TL. The effect of pituitary adenylate cyclase activating peptide (PACAP) on the nociceptive formalin test. Neurosci. Lett. 1996;207:187–190
  46. Zhang Y, Sjolund B, Moller K, Hakanson R, Sundler F. Pituitary adenylate cyclase activating peptide produces a marked and long-lasting depression of a C-fibre-evoked flexion reflex. Neuroscience. 1993;57:733–737
  47. Zhou CJ, Shioda S, Yada T, Inagaki N, Pleasure SJ, Kikuyama S. PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. Curr. Protein. Pept. Sci. 2002;3:423–439
  48. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

☆ This work was supported by Hungarian Grants OTKA K72592, K73044, NK78059, CNK78480, ETT 04-364/2009 and the “Science, Please! Research Teams on Innovation” programme (SROP-4.2.2/08/1/2008-0011), as well as Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science. Zs. Helyes and D. Reglodi were supported by János Bolyai Postdoctoral Research Fellowship (Hungary), A. Markovics by Sanofi-Aventis.

PII: S0143-4179(10)00068-5

doi: 10.1016/j.npep.2010.06.004

Neuropeptides
Volume 44, Issue 5 , Pages 363-371 , October 2010

Article Tools

* Image Usage & Resolution